Somatic PTPN11 mutations in childhood acute myeloid leukaemia

British Journal of Haematology

Volumn 129, Issue 3, 2005, Pages 333-339

  Tartaglia, Marco ^a,b   Martinelli, Simone ^a   Iavarone, Ivano ^a   Cazzaniga, Giovanni ^c   Spinelli, Monica ^d   Giarin, Emanuela ^d   Petrangeli, Valentina ^a   Carta, Claudio ^a   Masetti, Riccardo ^e   Aricò, Maurizio ^f   Locatelli, Franco ^g   Basso, Giuseppe ^d   Sorcini, Mariella ^a   Pession, Andrea ^e   Biondi, Andrea ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f Ospedale dei Bambini G Di Cristina   (Italy)

^g FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Childhood acute myeloid leukaemia; FAB M5 subtype; PTPN11; SHP 2; Somatic mutation

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE SHP 2; RAS PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FLT3 GENE; FRENCH AMERICAN BRITISH CLASSIFICATION M5 SUBTYPE; GENE; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; KRAS2 GENE; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; ONCOGENE N RAS; PRIORITY JOURNAL; PTPN11 GENE; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TUMOR CLASSIFICATION;

ACUTE DISEASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FMS-LIKE TYROSINE KINASE 3; GENES, RAS; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, MONOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKOCYTE COUNT; MALE; MUTATION; NEOPLASM PROTEINS; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 20844439887     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05457.x     Document Type: Article

References (28)

1. Agazie, Y.M. & Hayman, M.J. (2003) Molecular mechanism for a role of SHP-2 in epidermal growth factor receptor signaling. Molecular and Cellular Biology, 23, 7875-7886.
2. Aricò, M., Biondi, A. & Pui, C.-H. (1997) Juvenile myelomonocytic leukemia. Blood, 90, 479-488.
3. Birnbaum, R.A., O'Marcaigh, A., Wardak, Z., Zhang, Y.Y., Dranoff, G., Jacks, T., Clapp, D.W. & Shannon, K.M. (2000) Nf1 and Gmcsf interact in myeloid leukemogenesis. Molecular Cell, 5, 189-195.
4. Chan, R.J., Leedy, M.B., Munugalavadla, V., Voorhorst, C.S., Li, Y., Yu, M. & Kapur, R. (2005) Human somatic PTPN11 mutations induce haematopoietic cell hypersensitivity to granulocyte-macrophage colony stimulating factor. Blood, First Edition Paper, DOI 10.1182/blood-2004-10-4002.
5. Chen, B., Bronson, R.T., Klaman, L.D., Hampton, T.G., Wang, J.F., Green, P.J., Magnuson, T., Douglas, P.S., Morgan, J.P. & Ned, B.G. (2000) Mice mutants for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nature Genetics, 24, 295-299.
6. Emanuel, P.D., Bates, L.J., Castleberry, R.P., Gualtieri, R.J. & Zuckerman, K.S. (1991) Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia haematopoietic progenitors. Blood, 77, 925-929.
7. Emanuel, P.D., Shannon, K.M. & Castleberry, R.P. (1996) Juvenile myelomonocitic leukemia: molecular understanding and prospects for therapy. Molecular Medicine Today, 2, 468-475.
8. Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A. & Goldstone, A. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukemia Working Parties. Blood, 92, 2322-2333.
9. Hof, P., Pluskey, S., Dhe-Paganon, S., Eck, M.J. & Shoelson, S.E. (1998) Crystal structure of the tyrosine phosphatase SHP-2. Cell, 92, 441-450.
10. Kelly, L.M. & Gilliland, D.G. (2002) Genetics of myeloid leukemias. Annual Reviews in Genomics and Human Genetics, 3, 179-198.
11. Loh, M.L., Vattikuti, S., Schubbert, S., Reynolds, M.G., Carlson, E., Lieuw, K.H., Cheng, J.W., Lee, CM., Stokoe, D., Bonifas, J.M., Curtiss, N.P., Gotlib, J., Meshinchi, S., Le Beau, M.M., Emanuel, P.D. & Shannon, K.M. (2004a) Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood, 103, 2325-2331.
12. Loh, M.L., Reynolds, M.G., Vattikuti, S., Gerbing, R.B., Alonzo, T.A., Carlson, E., Cheng, J.W., Lee, C.M., Lange, B.J. & Meshinchi, S. (2004b) PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group. Leukemia, 18, 1831-1834.
13. Loh, M.L., Martinelli, S., Cordeddu, V., Reynolds, M.G., Vattikuti, S., Lee, C.M., Wulfert, M., Germing, U., Haas, P., Niemeyer, C., Beran, M.E., Strom, S., Lübbert, M., Sorcini, M., Estey, E.H., Gattermann, N. & Tartaglia, M. (2005) Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leukemia Research, 29, 459-462.
14. Maroun, C.R., Naujokas, M.A., Holgado-Madruga, M., Wong, A. & Park, M. (2000) The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the Met receptor tyrosine kinase. Molecular and Cellular Biology, 20, 8513-8525.
15. Neel, B.G., Gu, H. & Pao, L. (2003) The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends in Biochemical Sciences, 28, 284-293.
16. Qu, C.K., Shi, Z.Q., Shen, R., Tsai, F.Y., Orkin, S.H. & Feng, G.S. (1997) A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development. Molecular and Cell Biology, 17, 5499-5507.
17. Qu, C.K., Yu, W.M., Azzarelli, B., Cooper, S., Broxmeyer, H.E. & Feng, G.S. (1998) Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells. Molecular and Cell Biology, 18, 6075-6082.
18. Qu, C.K., Nguyen, S., Chen, J. & Feng, G.S. (2001) Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood, 97, 911-914.
19. Saxton, T.M., Henkemeyer, M., Gasca, S., Shen, R., Rossi, D.J., Shalaby, F., Feng, G.S. & Pawson, T. (1997) Abnormal mesoderm pattering in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO Journal, 16, 2352-2364.
20. Saxton, T.M., Ciruna, B.G., Holmyard, D., Kulkarni, S., Harpal, K., Rossant, J. & Pawson, T. (2000) The SH2 tyrosine phosphatase Shp2 is required for mammalian limb development. Nature Genetics, 24, 420-423.
21. Shi, Z.-Q., Yu, D.-H., Park, M., Marshall, M. & Feng, G.-S. (2000) Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity. Molecular and Cellular Biology, 20, 1526-1536.
22. Tang, T.L., Freeman, Jr, R.M., O'Reilly, A.M., Neel, B.G. & Sokol, S.Y. (1995) The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell, 80, 473-483.
23. Tartaglia, M. & Gelb, B.D. (2005) Noonan syndrome and related disorders: genetics and pathogenesis. Annual Reviews in Genomics and Human Genetics, 6 (in press).
24. Tartaglia, M., Mehler, E.L., Goldberg, R., Zampino, G., Brunner, H.G., Kremer, H., van der Burgt, I., Crosby, A.H., Ion, A., Jeffery, S., Kalidas, K., Patton, M.A., Kucherlapati, R.S. & Gelb, B.D. (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nature Genetics, 29, 465-468.
25. Tartaglia, M., Niemeyer, C.M., Fragale, A., Song, X., Buechner, J., Jung, A., Hahlen, K., Hasle, H., Licht, J.D. & Gelb, B.D. (2003) Somatic PTPN11 mutations in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nature Genetics, 34, 148-150.
26. Tartaglia, M., Niemeyer, C.M., Shannon, K.M. & Loh, M.L. (2004a) SHP-2 and myeloid malignancies. Current Opinions in Hematology, 11, 44-50.
27. Tartaglia, M., Martinelli, S., Cazzaniga, G., Cordeddu, V., lavarone, I., Spinelli, M., Palmi, C., Carta, C., Pession, A., Aricò, M., Masera, G., Basso, G., Sorcini, M., Gelb, B.D. & Biondi, A. (2004b) Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia. Blood, 104, 307-313.
28. You, M., Flock, L.M., Yu, D. & Feng, G.-S. (2001) Modulation of the nuclear factor κB pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. Journal of Experimental Medicine, 193, 101-109.